Ophthal Medical News about macular degeneration

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/21/09

Dadgostar H et al. – Preclinical and early clinical data on these agents will be summarized and evaluated in the context of current age–related macular degeneration management guidelines, and the advantages as well as the challenges associated with siRNA therapies will be discussed.

<< Previous
ETX1 is over-expressed in the glaucomatous trabecular meshwork

Next >>
Update and commentary on the pro-drug bimatoprost and a putative...

Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration
Retina, 11/11/09 Relevance Score: 68%

Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09 Relevance Score: 68%

Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09 Relevance Score: 67%

Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections
Acta Ophthalmologica, 11/11/09 Relevance Score: 66%

Complement Factor H and the Bilaterality of Age-Related Macular Degeneration
Archives of Ophthalmology, 10/19/09 Relevance Score: 66%